Pancreatic cancer is one of the deadliest cancers and the third-leading cause of cancer-related death in the United States.

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why ...

A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical ...

When many of us think about how drugs work in the body, we may first think about how a drug gets into the body, such as a pill versus an injection. In the Gellman Group at the UW–Madison Department of ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Brain organoids allow researchers to personalize testing medications Psychiatric drug ...

For the millions of people using glucagon-like peptide-1 receptor agonists (GLP-1), a dose has long meant a weekly appointment with a needle. With the U.S. Food and Drug Administration (FDA) approving ...

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

Samsung and Alcedis will explore how Galaxy Watch biometric data can support clinical trials, digital endpoints, and drug ...

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...